Multi-step regulation of innate immune signaling by Kaposi's sarcoma-associated herpesvirus
- PMID: 25796211
- PMCID: PMC4575611
- DOI: 10.1016/j.virusres.2015.03.004
Multi-step regulation of innate immune signaling by Kaposi's sarcoma-associated herpesvirus
Abstract
The innate immune system provides an immediate and relatively non-specific response to infection with the aim of eliminating the pathogen before an infection can be fully established. Activation of innate immune response is achieved by production of pro-inflammatory cytokines and type I interferon (IFN). The IFN response in particular is one of the primary defenses utilized by the host innate immune system to control pathogen infection, like virus infection. Hence, viruses have learned to manipulate host immune control mechanisms to facilitate their propagation. Due to this, much work has been dedicated to the elucidation of the Kaposi's sarcoma-associated herpesvirus (KSHV)-mediated immune evasion tactics that antagonize a host's immune system. This review presents our current knowledge of the immune evasion strategies employed by KSHV at distinct stages of its life cycle to control a host's immune system with a focus on interferon signaling.
Keywords: Immune evasion; Innate immune response; Interferon; Kaposi's sarcoma.
Copyright © 2015 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Beyond Viral Interferon Regulatory Factors: Immune Evasion Strategies.J Microbiol Biotechnol. 2019 Dec 28;29(12):1873-1881. doi: 10.4014/jmb.1910.10004. J Microbiol Biotechnol. 2019. PMID: 31650769 Review.
-
Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.J Virol. 2017 Jul 27;91(16):e00632-17. doi: 10.1128/JVI.00632-17. Print 2017 Aug 15. J Virol. 2017. PMID: 28592529 Free PMC article.
-
Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.mBio. 2017 Oct 10;8(5):e00917-17. doi: 10.1128/mBio.00917-17. mBio. 2017. PMID: 29018115 Free PMC article.
-
Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Cytokine Growth Factor Rev. 2014 Oct;25(5):597-609. doi: 10.1016/j.cytogfr.2014.06.001. Epub 2014 Jun 21. Cytokine Growth Factor Rev. 2014. PMID: 25037686 Free PMC article. Review.
-
RIG-I Detects Kaposi's Sarcoma-Associated Herpesvirus Transcripts in a RNA Polymerase III-Independent Manner.mBio. 2018 Jul 3;9(4):e00823-18. doi: 10.1128/mBio.00823-18. mBio. 2018. PMID: 29970461 Free PMC article.
Cited by
-
MBL2 gene polymorphisms in HHV-8 infection in people living with HIV/AIDS.Retrovirology. 2018 Nov 27;15(1):75. doi: 10.1186/s12977-018-0456-8. Retrovirology. 2018. PMID: 30482213 Free PMC article.
-
Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.J Virol. 2021 Jun 10;95(13):e0000321. doi: 10.1128/JVI.00003-21. Epub 2021 Jun 10. J Virol. 2021. PMID: 33853962 Free PMC article.
-
Viral Inhibition of PRR-Mediated Innate Immune Response: Learning from KSHV Evasion Strategies.Mol Cells. 2016 Nov 30;39(11):777-782. doi: 10.14348/molcells.2016.0232. Epub 2016 Nov 18. Mol Cells. 2016. PMID: 27871174 Free PMC article. Review.
-
Kaposi sarcoma herpesvirus-associated cancers and related diseases.Curr Opin HIV AIDS. 2017 Jan;12(1):47-56. doi: 10.1097/COH.0000000000000330. Curr Opin HIV AIDS. 2017. PMID: 27662501 Free PMC article. Review.
-
Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.Virology. 2020 Feb;541:160-173. doi: 10.1016/j.virol.2019.12.011. Epub 2019 Dec 30. Virology. 2020. PMID: 32056714 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- R01 CA197153/CA/NCI NIH HHS/United States
- R01 HL110609/HL/NHLBI NIH HHS/United States
- AI105909/AI/NIAID NIH HHS/United States
- R01 DE025465/DE/NIDCR NIH HHS/United States
- CA31363/CA/NCI NIH HHS/United States
- HL110609/HL/NHLBI NIH HHS/United States
- CA115284/CA/NCI NIH HHS/United States
- R01 AI073099/AI/NIAID NIH HHS/United States
- R01 CA132637/CA/NCI NIH HHS/United States
- R01 CA031363/CA/NCI NIH HHS/United States
- CA180779/CA/NCI NIH HHS/United States
- R01 CA124332/CA/NCI NIH HHS/United States
- R01 AI116585/AI/NIAID NIH HHS/United States
- CA82057/CA/NCI NIH HHS/United States
- AI073099/AI/NIAID NIH HHS/United States
- R21 AI105909/AI/NIAID NIH HHS/United States
- R01 CA082057/CA/NCI NIH HHS/United States
- R01 DE023926/DE/NIDCR NIH HHS/United States
- P01 CA180779/CA/NCI NIH HHS/United States
- DE023926/DE/NIDCR NIH HHS/United States
- R01 CA115284/CA/NCI NIH HHS/United States
- AI116585/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources